Web Site Helps Alleviate Stress Associated with Caring for Children with Diabetes During the Holiday

AbbottHolidays often induce stress, but caring for children with diabetes this time of year can mean an additional layer of pressure. Parents and caregivers can visit a webiste to participate in live Web chats with diabetes specialists for expert advice on how to best manage a child's diabetes during the holidays, find social support and receive a free download of the 'Diabetes Fit Food' booklet for tips on healthy eating.

The Web site and tools are in response to a recent survey conducted by Children with Diabetes and sponsored by Abbott Diabetes Care which found that 93 percent of parents who had a child with diabetes reported it is challenging to stick to regular diabetes' routines during the holidays, defined as the time between Thanksgiving and New Year's. These parents also said their children experience more periods of uncontrolled blood glucose during this time, which can have serious health consequences. Because of these two factors - disrupted routines and fluctuating glucose levels - many parents said they feel the need to measure their child's glucose level during the holiday season "more often than usual."

Almost 60 percent of parents surveyed said stress levels increase when it comes to caring for children with diabetes during the holiday season, with the major challenge being the disruption of normal daily routines during this time. A majority of respondents said support from family, friends and healthcare professionals, as well as interactive educational tools, such as Web chats and online forums, would help decrease their anxiety and enable them to better manage their child's diabetes.

Online tools to help with caring for children with diabetes during the holidays will be available from Nov. 8, 2007 through Jan. 3, 2008.

For further information, please visit:
http://www.abbottdiabetescare.com

Additional resources:
http://www.childrenwithdiabetes.com
http://www.diabetes.org/home.jsp
http://www.abbott.com
http://www.dlife.com
http://www.diabetescontrolforlife.com
http://www.jdrf.org

About Abbott
Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.

Most Popular Now

Pfizer to provide U.S. government with 10 million …

Pfizer Inc. (NYSE: PFE) today announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candid...

GSK and Vir Biotechnology announce United States g…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) announced US government contracts totalling approximately $1 billion[1] (USD) to purchase so...

Primary endpoint met in COMET-TAIL Phase III trial…

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Vir) (Nasdaq: VIR) announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase...

Two billion doses of AstraZeneca’s COVID-19 vaccin…

AstraZeneca and its partners have released for supply two billion doses of their COVID-19 vaccine to more than 170 countries across every continent on the planet in the l...

Merck and Ridgeback's molnupiravir, an oral COVID-…

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the United Kingdom Medicines and Healthcare products Re...

Johnson & Johnson COVID-19 vaccine named one o…

The editors of Time announced that the Johnson & Johnson COVID-19 vaccine has been selected as one of Time's Best Inventions of 2021. The vaccine, for which Johnson & ...

New target for COVID-19 vaccines identified

Next generation vaccines for COVID-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, c...

Repurposing a familiar drug for COVID-19

For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines. Every day...

Safety concerns raised for neuroblastoma candidate…

St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Th...

Pfizer and BioNTech receive expanded U.S. FDA emer…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a ...

'Dancing molecules' successfully repair severe spi…

Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal ...

A target for potential cancer drugs may, in fact, …

In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyro...